The stroma reaction myofibroblast: a key player in the control of tumor cell behavior, Int J Dev Biol, vol.48, pp.509-526, 2004. ,
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res, vol.71, pp.614-638, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01431944
BRCA1 gene in breast cancer, J Cell Physiol, vol.196, pp.19-41, 2003. ,
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer, J Natl Cancer Inst, vol.95, pp.1482-1487, 2003. ,
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes, Breast Cancer Res, vol.11, p.47, 2009. ,
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations, Cancer Prev Res (Phila), vol.3, pp.48-61, 2010. ,
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufciency, Genes Chromosomes Cancer, vol.49, pp.78-90, 2010. ,
Bennaceur Griscelli A. Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene, Stem Cell Res, vol.24, pp.135-138, 2017. ,
Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-72, 2007. ,
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery, Blood, vol.12, pp.3254-62, 2011. ,
Significance analysis of microarrays applied to the ionizing radiation responseProc, Natl. Acad. Sci. U. S. A, vol.98, pp.5116-5121, 2001. ,
FactoMineR: An R Package for Multivariate Analysis, J. Stat. Softw, vol.25, pp.1-18, 2008. ,
GO-Elite: a flexible solution for pathway and ontology overrepresentation, Bioinforma. Oxf. Engl, vol.28, pp.2209-2210, 2012. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.15545-15550, 2005. ,
Integration of biological networks and gene expression data using Cytoscape, Nat. Protoc, vol.2, pp.2366-2382, 2007. ,
Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells, J Cell Mol Med, vol.12, pp.975-986, 2008. ,
An improved syngeneic orthotopic murine model of human breast cancer progression. K Breast Cancer Res Treat, vol.147, pp.501-513, 2014. ,
Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor development, Mol Cancer Ther, vol.1, pp.213-237, 2015. ,
Molecular modeling of the hypoxia-inducible factor 1 (HIF-1), Theoretical Chemistry Accounts, vol.101, pp.51-56, 1999. ,
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature, vol.394, pp.485-90, 1998. ,
Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1?, autophagy and ketone body production, Cell Cycle, vol.11, pp.4167-73, 2012. ,
Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis, Mol Cell Biol, vol.28, pp.718-749, 2008. ,
High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer, Breast Cancer Res Treat, vol.111, pp.475-80, 2008. ,
BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression, Br J Cancer, vol.101, pp.1168-74, 2009. ,
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, vol.399, pp.271-276, 1999. ,
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol Cell Biol, vol.16, pp.4604-4617, 1996. ,
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update, Virchows Arch, vol.459, pp.465-75, 2011. ,
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues, J Cell Biochem, vol.101, pp.695-711, 2007. ,
Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells, J Appl Physiol, vol.97, pp.1550-1558, 2004. ,
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, vol.5, pp.329-368, 2004. ,
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility, Cancer Res, vol.62, pp.5358-5364, 2002. ,
Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation, J Biol Chem, vol.281, pp.19700-19708, 2006. ,
Opposite regulation of epithelial-tomesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells, Int J Oncol, vol.38, pp.1759-66, 2011. ,
Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer, vol.2, pp.442-54, 2002. ,
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease, BMC Cancer, vol.12, p.120, 2012. ,
Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells, Mol Cancer Res, vol.14, pp.103-116, 2016. ,
Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis, J Pathol, vol.239, pp.484-95, 2016. ,
, Annexe 4 : Publication complémentaire
, Les MSCs BRCA1 +/-utilisées dans ce travail ont été différenciées à partir d'iPSCs. Les iPSCs BRCA1 +/-ont été générées par une méthode de transduction virale non-intégrative (virus de Sendaï) comprenant les facteurs Oct3/4, Sox2, Klf4 et c-Myc à partir de cellules mononuclées du sang cryopréservées d'une patiente de, p.56
, Cette lignée (PB38) ainsi obtenue a été caractérisée quant à l'expression des marqueurs de pluripotence, de son caryotype, de sa capacité à former des tératomes in vivo et de la présence d'une mutation sur le gène BRCA1. La lignée PB38 a fait l'objet d'une publication dans la revue Stem Cell
Étude des voies de signalisation du récepteur p75NTR impliquées dans la croissance des cellules de cancer du sein, 2010. ,
Reproduction in mammals ,
Global cancer statistics, CA Cancer J Clin, vol.65, pp.87-108, 2012. ,
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-386, 2015. ,
Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 -Tumeurs solides, p.122, 2013. ,
The frequency of cancer in France: Most recent data and trends ,
, Bull Cancer (Paris), vol.104, pp.20-29, 2017.
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011. ,
Breast cancer. Dare to do less, Science, vol.343, pp.1454-1456, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00478335
Male breast cancer: genetics, epigenetics, and ethical aspects, Ann Oncol Off J Eur Soc Med Oncol, vol.24, issue.8, pp.75-82, 2013. ,
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2, Breast Cancer Res BCR, vol.18, p.15, 2016. ,
Linkage of early-onset familial breast cancer to chromosome 17q21, Science, vol.250, pp.1684-1689, 1990. ,
The genetics of breast and ovarian cancer, Br J Cancer, vol.72, pp.805-812, 1995. ,
Inherited predisposition to breast and ovarian cancer, Am J Hum Genet, vol.55, pp.861-865, 1994. ,
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, pp.66-71, 1994. ,
Targeting the BRCA1/2 tumor suppressors, Curr Drug Targets, vol.15, pp.17-31, 2014. ,
Genetics of breast cancer: a topic in evolution, Ann Oncol Off J Eur Soc Med Oncol, vol.26, pp.1291-1299, 2015. ,
Inherited susceptibility to common cancers, N Engl J Med, vol.359, pp.2143-2153, 2008. ,
Cancer susceptibility and the functions of BRCA1 and BRCA2, Cell, vol.108, pp.171-182, 2002. ,
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer, J Natl Cancer Inst, vol.95, pp.1482-1485, 2003. ,
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes, Breast Cancer Res BCR, vol.11, p.47, 2009. ,
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer, N Engl J Med, vol.374, pp.454-468, 2016. ,
The prevalence of BRCA2 mutations in familial pancreatic cancer, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.16, pp.342-346, 2007. ,
BRCA1 and BRCA2 families and the risk of skin cancer, Fam Cancer, vol.9, pp.489-493, 2010. ,
, TNM Classification of Malignant Tumours
,
Breast cancer intrinsic subtype classification, clinical use and future trends, Am J Cancer Res, vol.5, pp.2929-2943, 2015. ,
Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database, Clin Breast Cancer, vol.10, pp.294-300, 2010. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, vol.98, pp.10869-10874, 2001. ,
, Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours, Nature, vol.490, pp.61-70, 2012.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, p.346 ,
A new genome-driven integrated classification of breast cancer and its implications, EMBO J, vol.32, pp.617-628, 2013. ,
Hallmarks of "BRCAness" in sporadic cancers, Nat Rev Cancer, vol.4, pp.814-819, 2004. ,
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers, Br J Cancer, vol.108, pp.2172-2177, 2013. ,
BRCAness revisited, Nat Rev Cancer, vol.16, pp.110-120, 2016. ,
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer, Cell Stem Cell, vol.17, pp.260-271, 2015. ,
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells, Cell Stem Cell, vol.7, pp.403-417, 2010. ,
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits, Breast Cancer Res BCR, vol.17, p.85, 2015. ,
BRCA1 gene in breast cancer, J Cell Physiol, vol.196, pp.19-41, 2003. ,
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing, Nature, vol.477, pp.179-184, 2011. ,
BRCA1 regulation of transcription, Cancer Lett, vol.236, pp.175-185, 2006. ,
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities, Nat Genet, vol.12, pp.191-194, 1996. ,
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos, Genes Dev, vol.11, pp.1226-1241, 1997. ,
Structure-Function Of The Tumor Suppressor BRCA1, Comput Struct Biotechnol J, vol.1, 2012. ,
BRCA1 and its toolbox for the maintenance of genome integrity, Nat Rev Mol Cell Biol, vol.11, pp.138-148, 2010. ,
Insights into the functions of BRCA1 and BRCA2, Trends Genet TIG, vol.16, pp.69-74, 2000. ,
BRCA2 and predisposition to pancreatic and other cancers, Expert Rev Mol Med, vol.3, pp.1-10, 2001. ,
Inherited breast cancer: an emerging picture, Clin Genet, vol.54, pp.447-458, 1998. ,
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity, Oncogene, vol.20, pp.77-87, 2001. ,
BRCA1: the enigma of tissue-specific tumor development, Trends Genet TIG, vol.19, pp.312-315, 2003. ,
The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues, Nat Genet, vol.11, pp.17-26, 1995. ,
Regulation of BRCA1 expression and its relationship to sporadic breast cancer, Breast Cancer Res BCR, vol.5, pp.45-52, 2003. ,
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells, FASEB J Off Publ Fed Am Soc Exp Biol, vol.14, pp.1585-1594, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-01663881
Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens, Carcinogenesis, vol.21, pp.1761-1765, 2000. ,
Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis, Breast Cancer Res Treat, vol.142, pp.619-627, 2013. ,
Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway, Proc Natl Acad Sci U S A, vol.111, pp.4472-4477, 2014. ,
The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells, Front Oncol, vol.3, p.228, 2013. ,
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature, vol.434, pp.913-917, 2005. ,
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, vol.434, pp.917-921, 2005. ,
Mutation and cancer: statistical study of retinoblastoma, Proc Natl Acad Sci U S A, vol.68, pp.820-823, 1971. ,
Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers, Genes Chromosomes Cancer, vol.28, pp.432-442, 2000. ,
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells, Proc Natl Acad Sci U S A, vol.108, pp.17773-17778, 2011. ,
p53 mutations in human cancers, Science, vol.253, pp.49-53, 1991. ,
, Hum Mutat, vol.21, pp.292-300, 2003.
BRCA1--sowing the seeds crooked in the furrow, Nat Genet, vol.40, pp.8-9, 2008. ,
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression, Nat Genet, vol.9, pp.444-450, 1995. ,
Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas, Cancer, vol.92, pp.54-60, 2001. ,
Prognostic significance of BRCA1 expression in sporadic breast carcinomas, J Pathol, vol.200, pp.207-213, 2003. ,
Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer, Int J Cancer J Int Cancer, vol.88, pp.204-208, 2000. ,
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer, Br J Cancer, vol.73, pp.1220-1226, 1996. ,
Haplo-insufficiency of BRCA1 in sporadic breast cancer, Cancer Res, vol.63, pp.4978-4983, 2003. ,
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2, Int J Cancer J Int Cancer, vol.97, pp.557-561, 2002. ,
Frequency of BRCA1 dysfunction in ovarian cancer, J Natl Cancer Inst, vol.94, pp.61-67, 2002. ,
Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers, Int J Cancer J Int Cancer, vol.87, pp.317-321, 2000. ,
Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases, Clin Cancer Res Off J Am Assoc Cancer Res, vol.5, pp.1249-1261, 1999. ,
An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers, Int J Cancer J Int Cancer, vol.79, pp.334-342, 1998. ,
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas, Nat Genet, vol.21, pp.236-240, 1999. ,
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study, Cancer Res, vol.60, pp.5329-5333, 2000. ,
GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter, Oncogene, vol.19, pp.1933-1940, 2000. ,
BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer, Cell, vol.102, pp.257-265, 2000. ,
Tumor suppressor p53 is required to modulate BRCA1 expression, Mol Cell Biol, vol.20, pp.7450-7459, 2000. ,
BRCA1 is a component of the RNA polymerase II holoenzyme, Proc Natl Acad Sci U S A, vol.94, pp.5605-5610, 1997. ,
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity, Proc Natl Acad Sci U S A, vol.98, pp.5134-5139, 2001. ,
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress, Genes Dev, vol.14, pp.2989-3002, 2000. ,
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations, Cancer Prev Res Phila Pa, vol.3, pp.48-61, 2010. ,
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency, Genes Chromosomes Cancer, vol.49, pp.78-90, 2010. ,
Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate, Cell Stem Cell, vol.8, pp.149-163, 2011. ,
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat Med, vol.15, pp.907-913, 2009. ,
BRCA1 regulates human mammary stem/progenitor cell fate, Proc Natl Acad Sci U S A, vol.105, pp.1680-1685, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01431959
Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues, BMC Cancer, vol.10, p.9, 2010. ,
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2, Oncogene, vol.18, pp.7334-7342, 1999. ,
Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers, Breast Cancer Basic Clin Res, vol.9, pp.25-29, 2015. ,
BRCA1/2 Mutation-associated Breast Cancer, Wide Local Excision and Radiotherapy or Unilateral Mastectomy: A Systematic Review, Clin Oncol R Coll Radiol G B, vol.27, pp.527-535, 2015. ,
Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression, Proc Natl Acad Sci U S A, vol.109, pp.16654-16659, 2012. ,
The distribution of secondary growths in cancer of the breast. 1889, Cancer Metastasis Rev, vol.8, pp.98-101, 1989. ,
Microenvironmental regulation of metastasis, Nat Rev Cancer, vol.9, pp.239-252, 2009. ,
Fibroblast heterogeneity in the cancer wound, J Exp Med, vol.211, pp.1503-1523, 2014. ,
Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences, J Cell Mol Med, vol.15, pp.635-646, 2011. ,
Fibroblasts in cancer, Nat Rev Cancer, vol.6, pp.392-401, 2006. ,
Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression, Cancer Lett, vol.361, pp.155-163, 2015. ,
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers, Am J Pathol, vol.174, pp.2023-2034, 2009. ,
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, vol.121, pp.335-348, 2005. ,
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through ?1 integrin, Breast Cancer Res Treat, vol.133, pp.459-471, 2012. ,
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells, Cancer Biol Ther, vol.12, pp.924-938, 2011. ,
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met, Breast Cancer Res BCR, vol.14, p.104, 2012. ,
Mesenchymal stem cell homing: the devil is in the details, Cell Stem Cell, vol.4, pp.206-216, 2009. ,
Mesenchymal stem cells in the pathogenesis and therapy of breast cancer, J Mammary Gland Biol Neoplasia, vol.15, pp.399-409, 2010. ,
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe, Cytotherapy, vol.10, pp.657-667, 2008. ,
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells, Cancer Res, vol.68, pp.4331-4339, 2008. ,
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression, PloS One, vol.4, p.4992, 2009. ,
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.449, pp.557-563, 2007. ,
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging, Stem Cells Dayt Ohio, vol.27, pp.2614-2623, 2009. ,
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles, Cancer Res, vol.69, pp.8862-8867, 2009. ,
Review of mesenchymal stem cells and tumors: executioner or coconspirator?, Cancer Biother Radiopharm, vol.24, pp.717-721, 2009. ,
Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-?, Sci Rep, vol.5, p.16941, 2015. ,
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells, Gene Ther, vol.15, pp.730-738, 2008. ,
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res, vol.71, pp.614-624, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01431944
Inflammation and cancer, Nature, vol.420, pp.860-867, 2002. ,
Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer, vol.4, pp.71-78, 2004. ,
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, J Pathol, vol.196, pp.254-265, 2002. ,
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, vol.124, pp.263-266, 2006. ,
The hosttumor immune conflict: from immunosuppression to resistance and destruction, Immunol Today, vol.18, pp.493-497, 1997. ,
The role of myeloid cells in the promotion of tumour angiogenesis, Nat Rev Cancer, vol.8, pp.618-631, 2008. ,
Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies, Anticancer Res, vol.25, pp.3799-3807, 2005. ,
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?, Nat Rev Cancer, vol.2, pp.826-835, 2002. ,
Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells, Crit Rev Immunol, vol.30, pp.529-545, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00591659
Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo, Clin Cancer Res Off J Am Assoc Cancer Res, vol.15, pp.3265-3276, 2009. ,
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment, J Clin Invest, vol.115, pp.1163-1176, 2005. ,
Stromal cells in tumor microenvironment and breast cancer, Cancer Metastasis Rev, vol.32, pp.303-315, 2013. ,
Etude de la formation d'agrégats multicellulaires de carcinomes ovariens et du remodelage du microenvironnement tumoral, 2010. ,
The regulation of tenascin expression by tissue microenvironments, Biochim Biophys Acta, vol.1793, pp.888-892, 2009. ,
,
, J Soc Biol, vol.193, pp.423-428, 1999.
Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, vol.141, pp.52-67, 2010. ,
Matrix metalloproteinases in tumor invasion: role for cell migration, Pathol Int, vol.52, pp.255-264, 2002. ,
Matrix metalloproteinases as breast cancer drivers and therapeutic targets, Front Biosci Landmark Ed, vol.20, pp.1144-1163, 2015. ,
Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I, Biochem J, vol.294, pp.271-278, 1993. ,
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta, J Bone Miner Res Off J Am Soc Bone Miner Res, vol.14, pp.1239-1249, 1999. ,
Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration, Arterioscler Thromb Vasc Biol, vol.25, pp.77-83, 2005. ,
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility, Cancer Res, vol.62, pp.5358-5364, 2002. ,
periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype, Mol Cell Biol, vol.25, pp.11131-11144, 2005. ,
Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell, Cell Mol Life Sci CMLS, vol.68, pp.3201-3207, 2011. ,
The role of periostin in tissue remodeling across health and disease, Cell Mol Life Sci CMLS, vol.71, pp.1279-1288, 2014. ,
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues, J Cell Biochem, vol.101, pp.695-711, 2007. ,
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, vol.5, pp.329-339, 2004. ,
Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression, Mol Cell Biol, vol.24, pp.3992-4003, 2004. ,
Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells, PloS One, vol.8, p.72962, 2013. ,
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update, Virchows Arch Int J Pathol, vol.459, pp.465-475, 2011. ,
The multifaceted role of periostin in priming the tumor microenvironments for tumor progression, Cell Mol Life Sci CMLS, 2017. ,
Interactions between cancer stem cells and their niche govern metastatic colonization, Nature, vol.481, pp.85-89, 2011. ,
Microenvironmental regulation of tumor progression and metastasis, Nat Med, vol.19, pp.1423-1437, 2013. ,
Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases, Int J Cancer, vol.128, pp.352-360, 2011. ,
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo, Clin Cancer Res Off J Am Assoc Cancer Res, vol.14, pp.6797-6803, 2008. ,
Expression of periostin in human breast cancer, J Clin Pathol, vol.61, pp.494-498, 2008. ,
Quantitative proteomic profiling of matched normal and tumor breast tissues, J Proteome Res, vol.9, pp.3891-3902, 2010. ,
Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer, Breast Cancer Res Treat, vol.77, pp.245-252, 2003. ,
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy, Proc Natl Acad Sci U S A, vol.109, pp.17460-17465, 2012. ,
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies, Cell Cycle Georget Tex, vol.11, pp.4402-4413, 2012. ,
Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1?, autophagy and ketone body production, Cell Cycle Georget Tex, vol.11, pp.4167-4173, 2012. ,
Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation, Cancer Res, vol.76, pp.5395-5404, 2016. ,
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells, Cancer Res, vol.68, pp.10257-10266, 2008. ,
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis, Cell Stem Cell, vol.15, pp.762-774, 2014. ,
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome, J Pathol, vol.214, pp.357-367, 2008. ,
Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, pp.131-142, 2006. ,
The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, vol.133, pp.704-715, 2008. ,
Epithelial plasticity: a common theme in embryonic and cancer cells, Science, vol.342, p.1234850, 2013. ,
, Cell, vol.166, pp.21-45, 2016.
The basics of epithelial-mesenchymal transition, J Clin Invest, vol.119, pp.1420-1428, 2009. ,
The early steps of neural crest development, Mech Dev, vol.105, pp.27-35, 2001. ,
Mechanisms, mechanics and function of epithelialmesenchymal transitions in early development, Mech Dev, vol.120, pp.1351-1383, 2003. ,
Epithelial-mesenchymal transition, J Cell Sci, vol.118, pp.4325-4326, 2005. ,
Erk5 controls Slug expression and keratinocyte activation during wound healing, Mol Biol Cell, vol.19, pp.4738-4749, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00318681
Epithelial-mesenchymal transitions in development and disease, Cell, vol.139, pp.871-890, 2009. ,
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium, Am J Physiol Cell Physiol, vol.290, pp.1532-1542, 2006. ,
Evidence that fibroblasts derive from epithelium during tissue fibrosis, J Clin Invest, vol.110, pp.341-350, 2002. ,
Epithelial-mesenchymal transition and its implications for fibrosis, J Clin Invest, vol.112, pp.1776-1784, 2003. ,
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells, Breast Cancer Res BCR, vol.14, p.15, 2012. ,
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer, Mol Cancer Ther, vol.11, pp.2526-2534, 2012. ,
Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis, BMC Cancer, vol.12, p.114, 2012. ,
CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells, Breast Cancer Res BCR, vol.8, p.7, 2006. ,
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-tomesenchymal transition, Breast Cancer Res BCR, vol.13, p.211, 2011. ,
The morphological and molecular features of the epithelial-to-mesenchymal transition, Nat Protoc, vol.4, pp.1591-1613, 2009. ,
, Massagué J. TGFbeta in Cancer. Cell, vol.134, pp.215-230, 2008.
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer Cell, vol.13, pp.23-35, 2008. ,
Molecular biology of bone metastasis, Mol Cancer Ther, vol.6, pp.2609-2617, 2007. ,
Role of tissue stroma in cancer cell invasion, J Pathol, vol.200, pp.429-447, 2003. ,
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis, Cancer Cell, vol.15, pp.389-401, 2009. ,
BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development, Cancer Res, 2014. ,
Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation, Oncogene, vol.32, pp.2715-2725, 2013. ,
The transcriptional repressor Snail promotes mammary tumor recurrence, Cancer Cell, vol.8, pp.197-209, 2005. ,
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers, Oncogene, vol.31, pp.3667-3678, 2012. ,
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression, Trends Cell Biol, 2015. ,
Hypoxic regulation of metastasis via hypoxia-inducible factors, Curr Mol Med, vol.8, pp.60-67, 2008. ,
Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-?, Int J Cancer J Int Cancer, vol.134, pp.2583-2594, 2014. ,
Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells, Cancer Sci, vol.104, pp.157-164, 2013. ,
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT), Breast Cancer Res Treat, vol.124, pp.317-326, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00530824
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-? signalling, Br J Cancer, vol.110, pp.724-732, 2014. ,
Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation, J Biol Chem, vol.281, pp.19700-19708, 2006. ,
Opposite regulation of epithelial-tomesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells, Int J Oncol, vol.38, pp.1759-1766, 2011. ,
Mechanisms of angiogenesis, Nature, vol.386, pp.671-674, 1997. ,
Coordinating cell behaviour during blood vessel formation, Dev Camb Engl, vol.138, pp.4569-4583, 2011. ,
Inhibition de l'angiogenèse tumorale : criblage d'une chimiothèque et caractérisation d'un nouveau composé agissant sur la voie de signalisation Ras-ERK, 2014. ,
Molecular mechanisms and clinical applications of angiogenesis, Nature, vol.473, pp.298-307, 2011. ,
Basement membranes: structure, assembly and role in tumour angiogenesis, Nat Rev Cancer, vol.3, pp.422-433, 2003. ,
Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, pp.1182-1186, 1971. ,
Angiogenesis in cancer and other diseases, Nature, vol.407, pp.249-257, 2000. ,
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, vol.307, pp.58-62, 2005. ,
Angiogenesis in endocrine tumors, Endocr Rev, vol.24, pp.600-632, 2003. ,
Angiogenesis in health and disease, Nat Med, vol.9, pp.653-660, 2003. ,
Tumor induction of VEGF promoter activity in stromal cells, Cell, vol.94, pp.715-725, 1998. ,
Hypoxia and cancer, J Mol Med Berl Ger, vol.85, pp.1301-1307, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00319797
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes, J Biol Chem, vol.272, pp.22642-22647, 1997. ,
The role of hypoxia-induced factors in tumor progression, The Oncologist, vol.9, issue.5, pp.10-17, 2004. ,
BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression, Br J Cancer, vol.101, pp.1168-1174, 2009. ,
BRCA1 mutations in primary breast and ovarian carcinomas, Science, vol.266, pp.120-122, 1994. ,
Hypoxia-induced down-regulation of BRCA1 expression by E2Fs, Cancer Res, vol.65, pp.11597-11604, 2005. ,
BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression, J Biol Chem, vol.281, pp.13047-13056, 2006. ,
HIF-1? overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers, PloS One, vol.8, p.56055, 2013. ,
Lysyl oxidase is essential for hypoxiainduced metastasis, Nature, vol.440, pp.1222-1226, 2006. ,
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells, Cancer Cell, vol.19, pp.512-526, 2011. ,
Periostin mediates the increased pro-angiogenic activity of gastric cancer cells under hypoxic conditions, J Biochem Mol Toxicol, vol.27, pp.364-369, 2013. ,
Establishment in culture of pluripotential cells from mouse embryos, Nature, vol.292, pp.154-156, 1981. ,
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, Proc Natl Acad Sci U S A, vol.78, pp.7634-7638, 1981. ,
The construction of transgenic and gene knockout/knockin mouse models of human disease, Transgenic Res, vol.21, pp.327-349, 2012. ,
Induced Pluripotent Stem Cells Meet Genome Editing, Cell Stem Cell, vol.18, pp.573-586, 2016. ,
Embryonic stem cell lines derived from human blastocysts, Science, vol.282, pp.1145-1147, 1998. ,
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, vol.126, pp.663-676, 2006. ,
Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-872, 2007. ,
Induced pluripotent stem cell lines derived from human somatic cells, Science, vol.318, pp.1917-1920, 2007. ,
Morphological analysis of human induced pluripotent stem cells during induced differentiation and reverse programming, BioResearch Open Access, vol.3, pp.206-216, 2014. ,
Derivation, characterization, and differentiation of human embryonic stem cells, Stem Cells Dayt Ohio, vol.22, pp.367-376, 2004. ,
Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei, Nature, vol.182, pp.64-65, 1958. ,
Viable offspring derived from fetal and adult mammalian cells, Cloning Stem Cells, vol.9, pp.3-7, 2007. ,
Pluripotent teratocarcinoma-thymus somatic cell hybrids, Cell, vol.9, pp.45-55, 1976. ,
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, vol.471, pp.68-73, 2011. ,
Generation of germline-competent induced pluripotent stem cells, Nature, vol.448, pp.313-317, 2007. ,
Methods for making induced pluripotent stem cells: reprogramming à la carte, Nat Rev Genet, vol.12, pp.231-242, 2011. ,
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, Proc Jpn Acad Ser B Phys Biol Sci, vol.85, pp.348-362, 2009. ,
Human induced pluripotent stem cells free of vector and transgene sequences, Science, vol.324, pp.797-801, 2009. ,
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, vol.7, pp.618-630, 2010. ,
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, Cell Stem Cell, vol.4, pp.472-476, 2009. ,
Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells, Stem Cells Dayt Ohio, vol.27, pp.2667-2674, 2009. ,
Technological overview of iPS induction from human adult somatic cells, Curr Gene Ther, vol.13, pp.73-92, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02345998
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency, Cell, vol.162, pp.412-424, 2015. ,
Identification of spectral modifications occurring during reprogramming of somatic cells, PloS One, vol.7, p.30743, 2012. ,
, Transcriptional Control of Somatic Cell Reprogramming. Trends Cell Biol, vol.26, pp.272-288, 2016.
Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells, Biochem Pharmacol, vol.86, pp.691-702, 2013. ,
Induced pluripotent stem cells: the new patient?, Nat Rev Mol Cell Biol, vol.13, pp.713-726, 2012. ,
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application, Stem Cell Rep, vol.2, pp.205-218, 2014. ,
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration, N Engl J Med, vol.376, pp.1038-1046, 2017. ,
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues, Transplantation, vol.6, pp.230-247, 1968. ,
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell Tissue Kinet, vol.3, pp.393-403, 1970. ,
Marrow stromal stem cells, J Cell Sci Suppl, vol.10, pp.63-76, 1988. ,
Mesenchymal stem cells, J Orthop Res Off Publ Orthop Res Soc, vol.9, pp.641-650, 1991. ,
A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse, J Bone Miner Res Off J Am Soc Bone Miner Res, vol.14, pp.700-709, 1999. ,
Mesenchymal stem cells: revisiting history, concepts, and assays, Cell Stem Cell, vol.2, pp.313-319, 2008. ,
Multilineage potential of adult human mesenchymal stem cells, Science, vol.284, pp.143-147, 0193. ,
A perivascular origin for mesenchymal stem cells in multiple human organs, Cell Stem Cell, vol.3, pp.301-313, 2008. ,
All MSCs are pericytes?, Cell Stem Cell, vol.3, pp.229-230, 2008. ,
Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis, Prog Clin Biol Res, vol.389, pp.271-280, 1994. ,
Homing of in vitro expanded Stro-1-or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment, Blood, vol.103, pp.3313-3319, 2004. ,
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation, Int J Lab Hematol, vol.31, pp.9-19, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00484856
Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies, Exp Hematol, vol.30, pp.783-791, 2002. ,
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells Dayt Ohio, vol.24, pp.1294-1301, 2006. ,
Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells, Arthritis Rheum, vol.46, pp.3349-3360, 2002. ,
Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity, Stem Cells Dayt Ohio, vol.27, pp.1142-1151, 2009. ,
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-317, 2006. ,
Cell-and gene-based approaches to tendon regeneration, J Shoulder Elbow Surg, vol.21, pp.278-294, 2012. ,
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow, FASEB J Off Publ Fed Am Soc Exp Biol, vol.18, pp.980-982, 2004. ,
Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells, Stem Cell Rev, vol.13, pp.68-78, 2017. ,
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery, Blood, vol.118, pp.3254-3262, 2011. ,
Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, vol.105, pp.1815-1822, 2005. ,
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, vol.103, pp.4619-4621, 2004. ,
How mesenchymal stem cells interact with tissue immune responses, Trends Immunol, vol.33, pp.136-143, 2012. ,
TLR ligands stimulation protects MSC from NK killing, Stem Cells Dayt Ohio, vol.32, pp.290-300, 2014. ,
Immunomodulatory properties of mesenchymal stromal cells, Blood, vol.110, pp.3499-3506, 2007. ,
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, vol.31, pp.890-896, 2003. ,
Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives, Circulation, vol.109, pp.656-663, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00409575
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis, Stem Cells Dayt Ohio, vol.25, pp.2363-2370, 2007. ,
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis, Stem Cells Dayt Ohio, vol.25, pp.2648-2659, 2007. ,
Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis, PloS One, vol.7, p.35685, 2012. ,
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, vol.94, pp.678-685, 2004. ,
The MSC: an injury drugstore, Cell Stem Cell, vol.9, pp.11-15, 2011. ,
Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats, Cell Transplant, vol.21, pp.2009-2019, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00852839
Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction, Stem Cells Dayt Ohio, vol.27, pp.2734-2743, 0195. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410344
Trafficking and differentiation of mesenchymal stem cells, J Cell Biochem, vol.106, pp.984-991, 2009. ,
Therapeutic applications of mesenchymal stromal cells, Semin Cell Dev Biol, vol.18, pp.846-858, 2007. ,
Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications, Arch Pharm Res, vol.35, pp.213-221, 2012. ,
Phases I-III Clinical Trials Using Adult Stem Cells, Stem Cells Int, p.604713, 2010. ,
Significance analysis of microarrays applied to the ionizing radiation response, Proc Natl Acad Sci U S A, vol.98, pp.5116-5121, 2001. ,
FactoMineR: An R Package for Multivariate Analysis, J Stat Softw, vol.25, pp.1-18, 2008. ,
GO-Elite: a flexible solution for pathway and ontology over-representation, Bioinforma Oxf Engl, vol.28, pp.2209-2210, 2012. ,
Microenvironmental regulation of tumour angiogenesis, Nat Rev Cancer, vol.17, pp.457-474, 2017. ,
Tumor-associated endothelial cells with cytogenetic abnormalities, Cancer Res, vol.64, pp.8249-8255, 2004. ,
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas, N Engl J Med, vol.351, pp.250-259, 2004. ,
BRCA1 haploinsufficiency cellautonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells, Oncotarget, vol.8, pp.35019-35032, 2017. ,
Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab, Cell Cycle Georget Tex, vol.16, pp.1022-1028, 2017. ,
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers, Nat Med, vol.22, pp.933-939, 2016. ,
Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome, Oncotarget, vol.7, pp.11959-11971, 2016. ,
Modeling familial cancer with induced pluripotent stem cells, Cell, vol.161, pp.240-254, 2015. ,
An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression, Cell Rep, vol.3, pp.2088-2099, 0196. ,
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation, Stem Cell Res, vol.17, pp.154-157, 2016. ,
Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies, Stem Cell Res, vol.17, pp.235-237, 2016. ,
Induced pluripotent stem cells and senescence: learning the biology to improve the technology, EMBO Rep, vol.11, pp.353-359, 2010. ,
Analysis of induced pluripotent stem cells from a BRCA1 mutant family, Stem Cell Rep, vol.1, pp.336-349, 2013. ,
Development of a 3D angiogenesis model to study tumour -endothelial cell interactions and the effects of anti-angiogenic drugs, Sci Rep, vol.7, p.2963, 2017. ,
Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks, Organogenesis, vol.2017, pp.1-12 ,
, Autres sources : -Institut National du Cancer, consulté de mai à septembre, 2017.
, -Fondation ARC pour la Recherche sur le cancer, consulté de mai à septembre, 2017.
, Haute Autorité de Santé, consulté de mai à septembre, 2017.
,
,
, -Recommandations et référentiels : femmes porteuses d'une mutation de BRCA1 ou BRCA2, 2017.
, Guide affection longue durée, Cancer du sein, HAS et INCa, Janvier 2010. -Guide patient, Les traitements des cancers du sein, Cancer Info, La Ligue et INCa, Octobre, 2013.